283 related articles for article (PubMed ID: 23921954)
1. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.
Chefer VI; Bäckman CM; Gigante ED; Shippenberg TS
Neuropsychopharmacology; 2013 Dec; 38(13):2623-31. PubMed ID: 23921954
[TBL] [Abstract][Full Text] [Related]
2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
Tejeda HA; Counotte DS; Oh E; Ramamoorthy S; Schultz-Kuszak KN; Bäckman CM; Chefer V; O'Donnell P; Shippenberg TS
Neuropsychopharmacology; 2013 Aug; 38(9):1770-9. PubMed ID: 23542927
[TBL] [Abstract][Full Text] [Related]
4. Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.
Van't Veer A; Bechtholt AJ; Onvani S; Potter D; Wang Y; Liu-Chen LY; Schütz G; Chartoff EH; Rudolph U; Cohen BM; Carlezon WA
Neuropsychopharmacology; 2013 Jul; 38(8):1585-97. PubMed ID: 23446450
[TBL] [Abstract][Full Text] [Related]
5. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
[TBL] [Abstract][Full Text] [Related]
6. Learned avoidance requires VTA KOR-mediated reductions in dopamine.
Robble MA; Bozsik ME; Wheeler DS; Wheeler RA
Neuropharmacology; 2020 May; 167():107996. PubMed ID: 32057802
[TBL] [Abstract][Full Text] [Related]
7. NMDA receptors on non-dopaminergic neurons in the VTA support cocaine sensitization.
Luo Y; Good CH; Diaz-Ruiz O; Zhang Y; Hoffman AF; Shan L; Kuang SY; Malik N; Chefer VI; Tomac AC; Lupica CR; Bäckman CM
PLoS One; 2010 Aug; 5(8):e12141. PubMed ID: 20808436
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
9. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Margolis EB; Karkhanis AN
Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
[TBL] [Abstract][Full Text] [Related]
11. Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward.
Gibb SL; Jeanblanc J; Barak S; Yowell QV; Yaka R; Ron D
J Neurosci; 2011 Feb; 31(6):2180-7. PubMed ID: 21307254
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
[TBL] [Abstract][Full Text] [Related]
13. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
[TBL] [Abstract][Full Text] [Related]
14. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
[TBL] [Abstract][Full Text] [Related]
15. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
16. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
17. Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
Liu SS; Pickens S; Burma NE; Ibarra-Lecue I; Yang H; Xue L; Cook C; Hakimian JK; Severino AL; Lueptow L; Komarek K; Taylor AMW; Olmstead MC; Carroll FI; Bass CE; Andrews AM; Walwyn W; Trang T; Evans CJ; Leslie FM; Cahill CM
J Neurosci; 2019 May; 39(21):4162-4178. PubMed ID: 30862664
[TBL] [Abstract][Full Text] [Related]
18. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy.
Meade JA; Alkhlaif Y; Contreras KM; Obeng S; Toma W; Sim-Selley LJ; Selley DE; Damaj MI
Psychopharmacology (Berl); 2020 Sep; 237(9):2777-2793. PubMed ID: 32529265
[TBL] [Abstract][Full Text] [Related]
20. Role of dopamine projections from ventral tegmental area to nucleus accumbens and medial prefrontal cortex in reinforcement behaviors assessed using optogenetic manipulation.
Han X; Jing MY; Zhao TY; Wu N; Song R; Li J
Metab Brain Dis; 2017 Oct; 32(5):1491-1502. PubMed ID: 28523568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
